300 related articles for article (PubMed ID: 1690984)
1. Specific antibody responses and generation of antigenic variants in chickens immunized against a virulent avian influenza virus.
Hinshaw VS; Sheerar MG; Larsen D
Avian Dis; 1990; 34(1):80-6. PubMed ID: 1690984
[TBL] [Abstract][Full Text] [Related]
2. Antigenic analysis of recent H1N1 influenza viruses with monoclonal antibodies.
Yamada A; Cao MS; Imanishi J; Oyama S; Abe A; Katagiri S
Acta Virol; 1991 Aug; 35(4):343-9. PubMed ID: 1724874
[TBL] [Abstract][Full Text] [Related]
3. Development and application of monoclonal antibodies against avian influenza virus nucleoprotein.
Yang M; Berhane Y; Salo T; Li M; Hole K; Clavijo A
J Virol Methods; 2008 Feb; 147(2):265-74. PubMed ID: 18006085
[TBL] [Abstract][Full Text] [Related]
4. Antigenic and phenotypic variants of a virulent avian influenza virus selected during replication in ducks.
Philpott MS; Easterday BC; Hinshaw VS
J Wildl Dis; 1989 Oct; 25(4):507-13. PubMed ID: 2810550
[TBL] [Abstract][Full Text] [Related]
5. Live vaccination with an H5-hemagglutinin-expressing infectious laryngotracheitis virus recombinant protects chickens against different highly pathogenic avian influenza viruses of the H5 subtype.
Pavlova SP; Veits J; Mettenleiter TC; Fuchs W
Vaccine; 2009 Aug; 27(37):5085-90. PubMed ID: 19573638
[TBL] [Abstract][Full Text] [Related]
6. Origin and molecular changes associated with emergence of a highly pathogenic H5N2 influenza virus in Mexico.
Horimoto T; Rivera E; Pearson J; Senne D; Krauss S; Kawaoka Y; Webster RG
Virology; 1995 Oct; 213(1):223-30. PubMed ID: 7483266
[TBL] [Abstract][Full Text] [Related]
7. Production and diagnostic application of monoclonal antibodies against influenza virus H5.
Yang M; Clavijo A; Graham J; Salo T; Hole K; Berhane Y
J Virol Methods; 2009 Dec; 162(1-2):194-202. PubMed ID: 19699764
[TBL] [Abstract][Full Text] [Related]
8. Comparative efficacy of North American and antigenically matched reverse genetics derived H5N9 DIVA marker vaccines against highly pathogenic Asian H5N1 avian influenza viruses in chickens.
Jadhao SJ; Lee CW; Sylte M; Suarez DL
Vaccine; 2009 Oct; 27(44):6247-60. PubMed ID: 19686695
[TBL] [Abstract][Full Text] [Related]
9. Expression of avian influenza virus hemagglutinin by recombinant fowlpox virus.
Tripathy DN; Schnitzlein WM
Avian Dis; 1991; 35(1):186-91. PubMed ID: 1851414
[TBL] [Abstract][Full Text] [Related]
10. The reactions of monoclonal antibodies with structural proteins of mumps virus.
Orvell C
J Immunol; 1984 May; 132(5):2622-9. PubMed ID: 6201553
[TBL] [Abstract][Full Text] [Related]
11. Protective efficacy of several vaccines against highly pathogenic H5N1 avian influenza virus under experimental conditions.
Veits J; Römer-Oberdörfer A; Helferich D; Durban M; Suezer Y; Sutter G; Mettenleiter TC
Vaccine; 2008 Mar; 26(13):1688-96. PubMed ID: 18291561
[TBL] [Abstract][Full Text] [Related]
12. [Multi-epitope DNA vaccines against avian influenza in chickens].
Peng JM; Tong GZ; Wang YF; Qiu HJ
Sheng Wu Gong Cheng Xue Bao; 2003 Sep; 19(5):623-7. PubMed ID: 15969096
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of a competitive enzyme-linked immunosorbent assay for detection of type A influenza antibodies in avian sera.
Shafer AL; Katz JB; Eernisse KA
Avian Dis; 1998; 42(1):28-34. PubMed ID: 9533078
[TBL] [Abstract][Full Text] [Related]
14. Different neutralization efficiency of neutralizing monoclonal antibodies against avian influenza H5N1 virus to virus strains from different hosts.
Huang H; Dan H; Zhou Y; Yu Z; Fan H; Tong T; Jin M; Chen H
Mol Immunol; 2007 Feb; 44(5):1052-5. PubMed ID: 16965815
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of inactivated influenza vaccines in market turkeys.
Karunakaran D; Newman JA; Halvorson DA; Abraham A
Avian Dis; 1987; 31(3):498-503. PubMed ID: 3118863
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of recombinant fowl poxvirus vaccine in protecting chickens against a highly pathogenic Mexican-origin H5N2 avian influenza virus.
Swayne DE; Beck JR; Mickle TR
Avian Dis; 1997; 41(4):910-22. PubMed ID: 9454926
[TBL] [Abstract][Full Text] [Related]
17. Neutralizing epitopes of the H5 hemagglutinin from a virulent avian influenza virus and their relationship to pathogenicity.
Philpott M; Easterday BC; Hinshaw VS
J Virol; 1989 Aug; 63(8):3453-8. PubMed ID: 2473218
[TBL] [Abstract][Full Text] [Related]
18. A recombinant vesicular stomatitis virus replicon vaccine protects chickens from highly pathogenic avian influenza virus (H7N1).
Kalhoro NH; Veits J; Rautenschlein S; Zimmer G
Vaccine; 2009 Feb; 27(8):1174-83. PubMed ID: 19135116
[TBL] [Abstract][Full Text] [Related]
19. Antigenic and immunogenic properties of baculovirus-expressed infectious bursal disease viral proteins.
Dybing JK; Jackwood DJ
Avian Dis; 1998; 42(1):80-91. PubMed ID: 9533084
[TBL] [Abstract][Full Text] [Related]
20. [Preparation and characterization of monoclonal antibodies against M2 protein of avian influenza virus].
Li YQ; Yang J; Zhang L; Wei L
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 May; 24(5):475-8. PubMed ID: 18466706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
